Compare Charles River Laboratories Intl. Inc (CRL) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Rush Street Interactive Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $232.53 (market cap $11.14B), while Rush Street Interactive Inc trades at $33.5 (market cap $3.45B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 3.2× Rush Street Interactive Inc's market cap. Which is the better fit depends on your goals.
| CRL | RSI | |
|---|---|---|
Market Cap | $11.14B | $3.45B |
Sector | Health | Technology |
52-Week High | $233.60 | $34.18 |
52-Week Low | $145.57 | $14.51 |
Enterprise Value | $14.00B | $3.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
RSI stock trades at $34.18, up 2.34% today, with a bullish technical signal from moving averages and strong institutional support. Recent Q1 2026 earnings beat expectations with EPS of $0.14 versus $0.12 expected, while revenue grew to $1.13B in 2025. The company expanded into Alberta with BetRivers launch, enhancing its online gaming footprint.
Outlook remains positive with 76.9% analyst buy ratings and a consensus price target of $29.44, though high valuation multiples (P/E 98.56) and overbought RSI levels near 77.56 pose near-term risks. Key catalysts include Q2 2026 earnings on July 29, 2026, and execution of the $100M share repurchase program.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
